We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Omnia and Intradigm Sign Deal for Nanomedicine Manufacture

News   Mar 30, 2006

 
Omnia and Intradigm Sign Deal for Nanomedicine Manufacture
 
 
Advertisement
 

RELATED ARTICLES

RNA Nanoparticles’ Rubbery Properties Help Them To Target Tumors

News

A new study shows that RNA nanoparticles have elastic and rubbery properties that help to explain why these particles target tumors so efficiently and why they possess lower toxicity in animal studies.

READ MORE

Collaborations Aim to Meet Unmet Clinical Needs in Biomarker Discovery and Characterization

News

Thermo Fisher Scientific announced agreements with AstraZeneca and the University of Nebraska Medical Center that will showcase new workflows to improve the throughput, robustness and standardization of clinical biomarker analysis.

READ MORE

A New Way To Synthesize Gold Nanoparticles Within Cancer Cells

News

A team has demonstrated, for the first time, a method of biosynthesizing plasmonic gold nanoparticles within cancer cells, without the need for conventional bench-top lab methods.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Applied Sciences Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE